Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
Sponsored by Michael J. Fox Foundation for Parkinson's Research
About this study
BLAAC PD is a research study to understand what Parkinson's disease looks like for Black and African American communities. BLAAC PD is happening at research centers around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to transform understanding of the genetics of Parkinson's disease and make that knowledge globally relevant.
Research studies have found connections between genes and Parkinson's disease (PD). But those results have mostly come from studies with non-Black or African American volunteers. BLAAC PD aims to learn more about gene changes that may cause Parkinson's in Black and African American people. Study volunteers at sites across the United States will attend one visit and will give either a blood or saliva sample, complete a smell test, and may be asked to complete a physical exam. This new data could lead to future Parkinson's tests and treatments for Black and African American people and it may help better understand disease in other groups, too. This pioneering initiative will fill a gap of knowledge about PD in Black and African American people.
Where this study is enrolling (11)
- I'm interested
University of Alabama at Birmingham
Birmingham, Alabama
- I'm interested
University of Florida
Gainesville, Florida
- I'm interested
Rush University
Chicago, Illinois
- I'm interested
University of Chicago
Chicago, Illinois
- I'm interested
Louisiana State University Health Sciences Center Shreveport
Shreveport, Louisiana
Show all 11 locations
- I'm interested
Ochsner Clinic Foundation
New Orleans, Louisiana
- I'm interested
University of Maryland
Baltimore, Maryland
- I'm interested
Washington University in St. Louis
St Louis, Missouri
- I'm interested
University Hospitals Cleveland Medical Center
Cleveland, Ohio
- I'm interested
Medical University of South Carolina
Charleston, South Carolina
- I'm interested
University of Texas Health Science Center, Houston
Houston, Texas
Who can participate
Inclusion criteria
- ✓for Control Participants:
- ✓Ability to provide informed consent
- ✓Age 50 years or older
- ✓Self-identify as Black or African American
Exclusion criteria
- ✕for Control Participants:
- ✕Diagnosis of Parkinson's Disease and/or neurological condition
- ✕Familial history of PD and/or neurodegenerative or psychiatric conditions
- ✕Unknown family history of PD and/or neurodegenerative or psychiatric conditions
- ✕Any conditions that, in the investigator's opinion, preclude the individual's ability to carry out study activities
- ✕If submitting a saliva sample, nothing by mouth (food, drink, gum, tobacco, or smoking) for 30 minutes prior to sample collection
- ✕Inclusion Criteria for Participants with a Diagnosis of PD:
- ✕Ability to provide informed consent
- ✕Age 18 years or older
- ✕Self-identify as Black or African American
- ✕Meet the Movement Disorder Society's clinical diagnostic criteria for Parkinson's disease
- ✕Exclusion Criteria for Participants with a Diagnosis of PD:
- ✕\- If submitting a saliva sample, nothing by mouth (food, drink, gum, tobacco, or smoking) for 30 minutes prior to sample collection
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.